His dedication to patient care ensures every step of your weight loss journey is thoughtfully planned and executed with your well-being in mind
Whats Next: Regulatory filing for weight management: by end of 2025 Submission for type 2 diabetes: expected in 2026 Drug discovered by Chugai, licensed by Lilly in 2018 Implication: Orforglipron could become the first once-daily oral GLP-1 therapy with potent glucose-lowering and weight-loss benefits, potentially disrupting the injectable incretin market
Content current as of April 22, 2026
Your brain's hunger signals begin normalizing, making it harder to stick to reduced calorie intake without the medication's support
Skin tightening, jawline contouring, and collagen-stimulating treatments have seen a surge in interest among those who want their outer appearance to reflect the hard work they have put into their health
In turn, these stresses might address concerns about access and affordability